More than 1,000 HIV scientists, clinicians, epidemiologists and public health experts convened in Atlanta for AIDS Vaccine 2010.
More than 1,000 HIV scientists, clinicians, epidemiologists and public health experts convened in Atlanta for AIDS Vaccine 2010. This year, the conference marked its 10th anniversary of providing an international platform for investigators to share and exchange ideas and research.
Much of the discussion at the meeting surrounded RV144 and correlates analysis that is currently underway. COL Nelson Michael presented the status on the search for correlates in a plenary session. Collaborators at more than 20 research institutes and academic centers are conducting research on samples from the study. Michael also described MHRP’s regional vaccine strategy that builds upon RV144, and a second approach to developing an effective HIV vaccine aimed at global protection.Read news story from The Bay Area Reporter Online.
The following is a complete list of oral abstracts and posters presented by MHRP staff and partners September 28 – October 1, in Atlanta, Georgia:
Plenary:
COL Nelson Michael
Correlates of Immunity: RV144 – Lessons Learned
Oral Presentations:
Sutchana Tabrasit
False HIV Seropositive among uninfected HIV vaccine recipients of phase III vaccine trial in Thailand
Jaranit Kaewkungwal
Exploratory Age-Stratified Analysis of Risk Taking Behaviors and Trial Participation Outcomes in the Thai Phase III HIV Vaccine Trial
Nusara Thaitawat
Enrollment and Beyond: Recruiting and Retaining 16,000 Participants and What Comes Next
Poster Presentations:
Supachai Rerks-Ngarm
Community Engagement; Experience from the Thai Phase III Prime-Boost HIV Vaccine Trial, RV144
Merlin Robb
RV 217: The Early Capture HIV Cohort Study (ECHO): A prospective study of acute HIV infection among high risk populations view poster
Michael Benenson
ECHO Study (Early Capture HIV Cohort): Efficient detection of acute HIV-1 Infections in Pattaya, Thailand (RV 217) view poster
Gustavo Kijak
Feasibility of high-throughput and low-cost high-resolution class I HLA typing of HIV vaccine trial cohorts in Southeast Asia view poster
Genetics of Fc Gamma Receptors IIa and IIIa in vaccine trial reagents to support the study of immune correlates in RV144 view poster
Peter Oballah
B cell depletion CD4 counts and viral load impact on ADCC, binding antibodies and neutralizing antibody profiles in HIV-1 subtype A chronically infected Ugandansview poster
Arthur Sekiziyivu
Participant retention of women in African HIV prevention efficacy trials: A critical literature review view poster
Richard Heipertz
HIV-1 subtype G strains play a major role in HIV-1 genetic complexity in Nigeriaview poster
Tina Peachman
Bacteriophage T4 displayed gp41 protein as HIV-1 vaccine candidate
Binding and accessibility of HIV-1 gp41 epitopes to human and murine monoclonal antibodies view poster
Gary Matyas
Differences in lipid binding of neutralizing and non neutralizing murine multi-specific monoclonal antibodies that bind to the same peptide epitopes view poster
Lindsey Wieczorek
HIV-1 neutralization using pooled versus individual PBMC donors as target cellsview poster
Julie Ake
HIV-1 genetic diversity in Bulgaria 2008-2009 view poster
Nicolas Steers
Differential proteasomal processing of HIV-1 Gag-p24 by human dendritic cells and CD4+ T-cells results in an altered epitope repertoire view poster
Mangala Rao
Adjuvant-Antigen formulations and route of immunization influence the induction of binding and neutralizing antibodies to HIV-1gp41 view poster
Zoltan Beck
Binding of HIV-1 to erythrocytes effects of antibodies on trans infection view poster
Camila Macedo
Comparative HIV entry and trafficking in lymphocytes and epithelial cell line models: Implications for the assessment of HIV-1 neutralizing antibodies view poster
Douglas Cork
Deconvolution of HIV-1 quasi-species clusters with the W-curve
Correlating HIV-1 gp120 sequence with neutralization data using W-curve heuristics
Bruce Brown
The role of NK cells in PBMC-based HIV-1 neutralization assays employing Renilla luciferase-expressing infectious molecular clones view poster
Agnes Chenine
Neutralization assay using a CD4+ T cell line and chimeric CRF01_AE IMC-LucR.T2A view poster
AFRIMS
Safety Profiles of ALVAC HIV and AIDSVAX Vaccines in the Phase III Community-Based Trial in Thailand
Photos: Global HIV Vaccine Enterprise